-
1
-
-
84861144765
-
Global iodine status in 2011 and trends over the past decade
-
Andersson M, Karumbunathan V, Zimmermann MB. Global iodine status in 2011 and trends over the past decade. J Nutr. 2012;142:744-750.
-
(2012)
J Nutr.
, vol.142
, pp. 744-750
-
-
Andersson, M.1
Karumbunathan, V.2
Zimmermann, M.B.3
-
2
-
-
84879192768
-
Global iodine nutrition: Where do we stand in 2013?
-
Pearce EN, Andersson M, Zimmermann MB. Global iodine nutrition: where do we stand in 2013? Thyroid. 2013;23:523-528.
-
(2013)
Thyroid.
, vol.23
, pp. 523-528
-
-
Pearce, E.N.1
Andersson, M.2
Zimmermann, M.B.3
-
3
-
-
42549138472
-
Reduce, recycle, reuse-iodotyrosine deiodinase in thyroid iodide metabolism
-
Kopp PA. Reduce, recycle, reuse-iodotyrosine deiodinase in thyroid iodide metabolism. N Engl J Med. 2008;358:1856-1859.
-
(2008)
N Engl J Med.
, vol.358
, pp. 1856-1859
-
-
Kopp, P.A.1
-
4
-
-
9444274840
-
Iodotyrosine dehalogenase 1 (DEHAL1) is a transmembrane protein involved in the recycling of iodide close to the thyroglobulin iodination site
-
Gnidehou S, Caillou B, Talbot M, et al. Iodotyrosine dehalogenase 1 (DEHAL1) is a transmembrane protein involved in the recycling of iodide close to the thyroglobulin iodination site. FASEB J. 2004;18:1574-1576.
-
(2004)
FASEB J.
, vol.18
, pp. 1574-1576
-
-
Gnidehou, S.1
Caillou, B.2
Talbot, M.3
-
5
-
-
33645891683
-
Mechanisms of adaptation to iodine deficiency in rats: Thyroid status is tissue specific. Its relevance for man
-
Pedraza PE, Obregon MJ, Escobar-Morreale HF, del Rey FE, de Escobar GM. Mechanisms of adaptation to iodine deficiency in rats: thyroid status is tissue specific. Its relevance for man. Endocrinology. 2006;147:2098-2108.
-
(2006)
Endocrinology
, vol.147
, pp. 2098-2108
-
-
Pedraza, P.E.1
Obregon, M.J.2
Escobar-Morreale, H.F.3
Del Rey, F.E.4
De Escobar, G.M.5
-
6
-
-
40449103287
-
Iodine deficiency induces a thyroid stimulating hormone-independent early phase of microvascular reshaping in the thyroid
-
Gérard AC, Poncin S, Caetano B, et al. Iodine deficiency induces a thyroid stimulating hormone-independent early phase of microvascular reshaping in the thyroid. Am J Pathol. 2008;172:748-760.
-
(2008)
Am J Pathol.
, vol.172
, pp. 748-760
-
-
Gérard, A.C.1
Poncin, S.2
Caetano, B.3
-
7
-
-
66849135086
-
Iodide deficiency-induced angiogenic stimulus in the thyroid occurs via HIF- and ROS-dependent VEGF-A secretion from thyrocytes
-
Gérard AC, Poncin S, Audinot JN, Denef JF, Colin IM. Iodide deficiency-induced angiogenic stimulus in the thyroid occurs via HIF- and ROS-dependent VEGF-A secretion from thyrocytes. Am J Physiol Endocrinol Metab. 2009;296:E1414-E1422.
-
(2009)
Am J Physiol Endocrinol Metab.
, vol.296
, pp. E1414-E1422
-
-
Gérard, A.C.1
Poncin, S.2
Audinot, J.N.3
Denef, J.F.4
Colin, I.M.5
-
8
-
-
84921635388
-
Involvement of nitric oxide in iodine deficiency-induced microvascular remodeling in the thyroid gland: Role of nitric oxide synthase 3 and ryanodine receptors
-
Craps J, Wilvers C, Joris V, et al. Involvement of nitric oxide in iodine deficiency-induced microvascular remodeling in the thyroid gland: role of nitric oxide synthase 3 and ryanodine receptors. Endocrinology. 2015;156:707-720.
-
(2015)
Endocrinology
, vol.156
, pp. 707-720
-
-
Craps, J.1
Wilvers, C.2
Joris, V.3
-
9
-
-
84863485749
-
Iodine-deficiency-induced long lasting angiogenic reaction in thyroid cancers occurs via a vascular endothelial growth factor-hypoxia inducible factor-1-dependent, but not a reactive oxygen species-dependent, pathway
-
Gérard AC, Humblet K, Wilvers C, et al. Iodine-deficiency-induced long lasting angiogenic reaction in thyroid cancers occurs via a vascular endothelial growth factor-hypoxia inducible factor-1-dependent, but not a reactive oxygen species-dependent, pathway. Thyroid. 2012;22:699-708.
-
(2012)
Thyroid
, vol.22
, pp. 699-708
-
-
Gérard, A.C.1
Humblet, K.2
Wilvers, C.3
-
10
-
-
77953857289
-
MTOR downregulates iodide uptake in thyrocytes
-
de Souza EC, Padrón AS, Braga WM, et al. MTOR downregulates iodide uptake in thyrocytes. J Endocrinol. 2010;206:113-120.
-
(2010)
J Endocrinol.
, vol.206
, pp. 113-120
-
-
De Souza, E.C.1
Padrón, A.S.2
Braga, W.M.3
-
12
-
-
84859778293
-
mTOR signaling in growth control and disease
-
Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149:274-293.
-
(2012)
Cell
, vol.149
, pp. 274-293
-
-
Laplante, M.1
Sabatini, D.M.2
-
13
-
-
0035200856
-
Amino acid-induced translation of TOP mRNAs is fully dependent on phosphatidylinositol 3-kinase-mediated signaling, is partially inhibited by rapamycin, and is independent of S6K1 and rpS6 phosphorylation
-
Tang H, Hornstein E, Stolovich M, et al. Amino acid-induced translation of TOP mRNAs is fully dependent on phosphatidylinositol 3-kinase-mediated signaling, is partially inhibited by rapamycin, and is independent of S6K1 and rpS6 phosphorylation. Mol Cell Biol. 2001;21:8671-8683.
-
(2001)
Mol Cell Biol.
, vol.21
, pp. 8671-8683
-
-
Tang, H.1
Hornstein, E.2
Stolovich, M.3
-
14
-
-
0036320934
-
Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression
-
Wenger RH. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J. 2002;16:1151-1162.
-
(2002)
FASEB J.
, vol.16
, pp. 1151-1162
-
-
Wenger, R.H.1
-
15
-
-
0029785838
-
Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene
-
Gnarra JR, Zhou S, Merrill MJ, et al. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc Natl Acad Sci USA. 1996;93:10589-10594.
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 10589-10594
-
-
Gnarra, J.R.1
Zhou, S.2
Merrill, M.J.3
-
16
-
-
34547134517
-
Hypoxia-inducible factor 1a is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif
-
Land SC, Tee AR. Hypoxia-inducible factor 1a is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif. J Biol Chem. 2007;282:20534-20543.
-
(2007)
J Biol Chem.
, vol.282
, pp. 20534-20543
-
-
Land, S.C.1
Tee, A.R.2
-
17
-
-
66849136781
-
Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer
-
Baselga J, Semiglazov V, van Dam P, et al. Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer. J Clin Oncol. 2009;27:2630-2637.
-
(2009)
J Clin Oncol.
, vol.27
, pp. 2630-2637
-
-
Baselga, J.1
Semiglazov, V.2
Van Dam, P.3
-
18
-
-
84931375496
-
Suppression of mTOR pathway in solid tumors: Lessons learned from clinical experience in renal cell carcinoma and neuroendocrine tumors and new perspectives
-
Ortolani S, Ciccarese C, Cingarlini S, Tortora G, Massari F. Suppression of mTOR pathway in solid tumors: lessons learned from clinical experience in renal cell carcinoma and neuroendocrine tumors and new perspectives. Future Oncol. 2015;11:1809-1828.
-
(2015)
Future Oncol.
, vol.11
, pp. 1809-1828
-
-
Ortolani, S.1
Ciccarese, C.2
Cingarlini, S.3
Tortora, G.4
Massari, F.5
-
19
-
-
84928413090
-
Dual targeting of acute myeloid leukemia progenitors by catalytic mTOR inhibition and blockade of the p110a subunit of PI3 kinase
-
Colamonici M, Blyth G, Saleiro D, et al. Dual targeting of acute myeloid leukemia progenitors by catalytic mTOR inhibition and blockade of the p110a subunit of PI3 kinase. Oncotarget. 2015;6:8062-8070.
-
(2015)
Oncotarget
, vol.6
, pp. 8062-8070
-
-
Colamonici, M.1
Blyth, G.2
Saleiro, D.3
-
20
-
-
82755195127
-
Activation of mTOR signaling in medullary and aggressive papillary thyroid carcinomas
-
Kouvaraki MA, Liakou C, Paraschi A, et al. Activation of mTOR signaling in medullary and aggressive papillary thyroid carcinomas. Surgery. 2011;150:1258-1265.
-
(2011)
Surgery
, vol.150
, pp. 1258-1265
-
-
Kouvaraki, M.A.1
Liakou, C.2
Paraschi, A.3
-
22
-
-
0042031047
-
A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets
-
Arsham AM, Howell JJ, Simon MC. A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets. J Biol Chem. 2003;278:29655-29660.
-
(2003)
J Biol Chem.
, vol.278
, pp. 29655-29660
-
-
Arsham, A.M.1
Howell, J.J.2
Simon, M.C.3
-
23
-
-
28844433635
-
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin
-
Shaw RJ, Lamia KA, Vasquez D, et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science. 2005;310:1642-1646.
-
(2005)
Science
, vol.310
, pp. 1642-1646
-
-
Shaw, R.J.1
Lamia, K.A.2
Vasquez, D.3
-
24
-
-
42949139481
-
AMPK phosphorylation of raptor mediates a metabolic checkpoint
-
Gwinn DM, Shackelford DB, Egan DF, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell. 2008;30:214-226.
-
(2008)
Mol Cell
, vol.30
, pp. 214-226
-
-
Gwinn, D.M.1
Shackelford, D.B.2
Egan, D.F.3
-
25
-
-
0029959652
-
Primary culture of human thyrocytes in transwell bicameral chamber: Thyrotropin promotes polarization and epithelial barrier function
-
Nilsson M, Husmark J, Nilsson B, Tisell LE, Ericson LE. Primary culture of human thyrocytes in transwell bicameral chamber: thyrotropin promotes polarization and epithelial barrier function. Eur J Endocrinol. 1996;135:469-480.
-
(1996)
Eur J Endocrinol.
, vol.135
, pp. 469-480
-
-
Nilsson, M.1
Husmark, J.2
Nilsson, B.3
Tisell, L.E.4
Ericson, L.E.5
-
26
-
-
0037326307
-
Physiological role of AMP-activated protein kinase (AMPK): Insights from knockout mouse models
-
Viollet B, Andreelli F, Jørgensen SB, et al. Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models. Biochem Soc Trans. 2003;31:216-219.
-
(2003)
Biochem Soc Trans
, vol.31
, pp. 216-219
-
-
Viollet, B.1
Andreelli, F.2
Jørgensen, S.B.3
-
27
-
-
84876068519
-
Recent insights into the cell biology of thyroid angiofollicular units
-
Colin IM, Denef JF, Lengelé B, Many MC, Gérard AC. Recent insights into the cell biology of thyroid angiofollicular units. Endocr Rev. 2013;34:209-238.
-
(2013)
Endocr Rev.
, vol.34
, pp. 209-238
-
-
Colin, I.M.1
Denef, J.F.2
Lengelé, B.3
Many, M.C.4
Gérard, A.C.5
-
28
-
-
0036789574
-
Regulation of hypoxia-inducible factor 1α expression and function by the mammalian target of rapamycin
-
Hudson CC, Liu M, Chiang GG, et al. Regulation of hypoxia-inducible factor 1α expression and function by the mammalian target of rapamycin. Mol Cell Biol. 2002;22:7004-7014.
-
(2002)
Mol Cell Biol.
, vol.22
, pp. 7004-7014
-
-
Hudson, C.C.1
Liu, M.2
Chiang, G.G.3
-
29
-
-
77955272978
-
P70S6K 1 regulation of angiogenesis through VEGF and HIF-1a expression
-
Bian CX, Shi Z, Meng Q, Jiang Y, Liu LZ, Jiang BH. P70S6K 1 regulation of angiogenesis through VEGF and HIF-1a expression. Biochem Biophys Res Commun. 2010;398:395-399.
-
(2010)
Biochem Biophys Res Commun.
, vol.398
, pp. 395-399
-
-
Bian, C.X.1
Shi, Z.2
Meng, Q.3
Jiang, Y.4
Liu, L.Z.5
Jiang, B.H.6
-
30
-
-
84865029396
-
Rapamycin inhibits proliferation of hemangioma endothelial cells by reducing HIF-1-dependent expression of VEGF
-
Medici D, Olsen BR. Rapamycin inhibits proliferation of hemangioma endothelial cells by reducing HIF-1-dependent expression of VEGF. PLoS One. 2012;7:e42913.
-
(2012)
PLoS One
, vol.7
, pp. e42913
-
-
Medici, D.1
Olsen, B.R.2
-
31
-
-
67649814136
-
PI3K/PTEN signaling in angiogenesis and tumorigenesis
-
Jiang BH, Liu LZ. PI3K/PTEN signaling in angiogenesis and tumorigenesis. Adv Cancer Res. 2009;102:19-65.
-
(2009)
Adv Cancer Res
, vol.102
, pp. 19-65
-
-
Jiang, B.H.1
Liu, L.Z.2
-
32
-
-
63449098382
-
mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor
-
Lane HA, Wood JM, McSheehy PM, et al. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor. Clin Cancer Res. 2009;15:1612-1622.
-
(2009)
Clin Cancer Res.
, vol.15
, pp. 1612-1622
-
-
Lane, H.A.1
Wood, J.M.2
McSheehy, P.M.3
-
33
-
-
4143111260
-
AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth
-
Altomare DA, Wang HQ, Skele KL, et al. AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene. 2004;23:5853-5857.
-
(2004)
Oncogene
, vol.23
, pp. 5853-5857
-
-
Altomare, D.A.1
Wang, H.Q.2
Skele, K.L.3
-
34
-
-
10244229652
-
In vivo antitumor effects of the mTOR inhibitor CCI-779 against human multiple myeloma cells in a xenograft model
-
Frost P, Moatamed F, Hoang B, et al. In vivo antitumor effects of the mTOR inhibitor CCI-779 against human multiple myeloma cells in a xenograft model. Blood. 2004;104:4181-4187.
-
(2004)
Blood
, vol.104
, pp. 4181-4187
-
-
Frost, P.1
Moatamed, F.2
Hoang, B.3
-
35
-
-
84909952958
-
Nerve growth factor regulates the expression of vascular endothelial growth factor in human HaCaT keratinocytes via PI3K/mTOR pathway
-
Zhang J, Ma WY. Nerve growth factor regulates the expression of vascular endothelial growth factor in human HaCaT keratinocytes via PI3K/mTOR pathway. Genet Mol Res. 2014;13:9324-9335.
-
(2014)
Genet Mol Res.
, vol.13
, pp. 9324-9335
-
-
Zhang, J.1
Ma, W.Y.2
-
36
-
-
79961075137
-
Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake
-
Ginion A, Auquier J, Benton CR, et al. Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake. Am J Physiol Heart Circ Physiol. 2011;301:H469-H477.
-
(2011)
Am J Physiol Heart Circ Physiol.
, vol.301
, pp. H469-H477
-
-
Ginion, A.1
Auquier, J.2
Benton, C.R.3
-
38
-
-
84858079914
-
A PI3K/AKT/mTOR pathway in angiogenesis
-
Karar J, Maity. A PI3K/AKT/mTOR pathway in angiogenesis. Front Mol Neurosci. 2011;4:51.
-
(2011)
Front Mol Neurosci.
, vol.4
, pp. 51
-
-
Karar, J.1
Maity2
-
39
-
-
2942624259
-
A common polymorphism in the oxygen-dependent degradation (ODD) domain of hypoxia inducible factor-1a (HIF-1a) does not impair Pro-564 hydroxylation
-
Percy MJ, Mooney SM, McMullin MF, Flores A, Lappin TR, Lee FS. A common polymorphism in the oxygen-dependent degradation (ODD) domain of hypoxia inducible factor-1a (HIF-1a) does not impair Pro-564 hydroxylation. Mol Cancer. 2003;2:31.
-
(2003)
Mol Cancer.
, vol.2
, pp. 31
-
-
Percy, M.J.1
Mooney, S.M.2
McMullin, M.F.3
Flores, A.4
Lappin, T.R.5
Lee, F.S.6
-
40
-
-
0031453135
-
The mammalian target of rapamycin phosphorylates sites having a (Ser/Thr)-Pro motif and is activated by antibodies to a region near its COOH terminus
-
Brunn GJ, Fadden P, Haystead TA, Lawrence JC Jr. The mammalian target of rapamycin phosphorylates sites having a (Ser/Thr)-Pro motif and is activated by antibodies to a region near its COOH terminus. J Biol Chem. 1997;272:32547-32550.
-
(1997)
J Biol Chem.
, vol.272
, pp. 32547-32550
-
-
Brunn, G.J.1
Fadden, P.2
Haystead, T.A.3
Lawrence, J.C.4
-
41
-
-
84863566153
-
mTOR pathway overactivation in BRAF mutated papillary thyroid carcinoma
-
Faustino A, Couto JP, Pópulo H, et al. mTOR pathway overactivation in BRAF mutated papillary thyroid carcinoma. J Clin Endocrinol Metab. 2012;97:E1139-E1149.
-
(2012)
J Clin Endocrinol Metab.
, vol.97
, pp. E1139-E1149
-
-
Faustino, A.1
Couto, J.P.2
Pópulo, H.3
-
42
-
-
84892163711
-
Impact of Metformin and compound C on NIS expression and iodine uptake in vitro and in vivo: A role for CRE in AMPK modulation of thyroid function
-
Abdulrahman RM, Boon MR, Sips HC, et al. Impact of Metformin and compound C on NIS expression and iodine uptake in vitro and in vivo: a role for CRE in AMPK modulation of thyroid function. Thyroid. 2014;24:78-87.
-
(2014)
Thyroid
, vol.24
, pp. 78-87
-
-
Abdulrahman, R.M.1
Boon, M.R.2
Sips, H.C.3
-
43
-
-
84881524522
-
Treatment with metformin is associated with higher remission rate in diabetic patientswith thyroidcancer
-
Klubo-Gwiezdzinska J, Costello J Jr, Patel A, et al. Treatment with metformin is associated with higher remission rate in diabetic patientswith thyroidcancer. J Clin Endocrinol Metab. 2013;98:3269-3279.
-
(2013)
J Clin Endocrinol Metab.
, vol.98
, pp. 3269-3279
-
-
Klubo-Gwiezdzinska, J.1
Costello, J.2
Patel, A.3
-
44
-
-
79955501998
-
Metformin treatment for small benign thyroid nodules in patients with insulin resistance
-
Rezzónico J, Rezzónico M, Pusiol E, Pitoia F, Niepomniszcze H. Metformin treatment for small benign thyroid nodules in patients with insulin resistance. Metab Syndr Relat Disord. 2011;9:69-75.
-
(2011)
Metab Syndr Relat Disord.
, vol.9
, pp. 69-75
-
-
Rezzónico, J.1
Rezzónico, M.2
Pusiol, E.3
Pitoia, F.4
Niepomniszcze, H.5
-
45
-
-
84940440029
-
Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTORpathway
-
Han B, Cui H, Kang L, et al. Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTORpathway. Tumour Biol. 2015;36:6295-6304.
-
(2015)
Tumour Biol.
, vol.36
, pp. 6295-6304
-
-
Han, B.1
Cui, H.2
Kang, L.3
-
46
-
-
83255187905
-
IRE1-dependent activation of AMPK in response to nitric oxide
-
Meares GP, Hughes KJ, Naatz A, et al. IRE1-dependent activation of AMPK in response to nitric oxide. Mol Cell Biol. 2011;31:4286-4297.
-
(2011)
Mol Cell Biol.
, vol.31
, pp. 4286-4297
-
-
Meares, G.P.1
Hughes, K.J.2
Naatz, A.3
-
47
-
-
84855603512
-
Cellular and molecular mechanisms of metformin: An overview
-
Viollet B, Guigas B, Sanz GN, Leclerc J, Foretz M, Andreelli F. Cellular and molecular mechanisms of metformin: an overview. Clin Sci (Lond). 2012;122:253-270.
-
(2012)
Clin Sci (Lond).
, vol.122
, pp. 253-270
-
-
Viollet, B.1
Guigas, B.2
Sanz, G.N.3
Leclerc, J.4
Foretz, M.5
Andreelli, F.6
-
48
-
-
84919615360
-
Metformin: From mechanisms of action to therapies
-
Foretz M, Guigas B, Bertrand L, Pollak M, Viollet B. Metformin: from mechanisms of action to therapies. Cell Metab. 2014;20:953-966.
-
(2014)
Cell Metab.
, vol.20
, pp. 953-966
-
-
Foretz, M.1
Guigas, B.2
Bertrand, L.3
Pollak, M.4
Viollet, B.5
-
49
-
-
0141960109
-
AMP-activated protein kinase activity is critical for hypoxia-inducible factor-1 transcriptional activity and its target gene expression under hypoxic conditions in DU145 cells
-
Lee M, Hwang JT, Lee HJ, et al. AMP-activated protein kinase activity is critical for hypoxia-inducible factor-1 transcriptional activity and its target gene expression under hypoxic conditions in DU145 cells. J Biol Chem. 2003;278:39653-39661.
-
(2003)
J Biol Chem.
, vol.278
, pp. 39653-39661
-
-
Lee, M.1
Hwang, J.T.2
Lee, H.J.3
-
50
-
-
18044393806
-
AMP-activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle
-
Ouchi N, Shibata R, Walsh K. AMP-activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle. Circ Res. 2005;96:838-846.
-
(2005)
Circ Res.
, vol.96
, pp. 838-846
-
-
Ouchi, N.1
Shibata, R.2
Walsh, K.3
-
51
-
-
84864676553
-
Fatty acids revert the inhibition of respiration caused by the antidiabetic drug metformin to facilitate their mitochondrial β-oxidation
-
González-Barroso MM, Anedda A, Gallardo-Vara E, et al. Fatty acids revert the inhibition of respiration caused by the antidiabetic drug metformin to facilitate their mitochondrial β-oxidation. Biochim Biophys Acta. 2012;1817:1768-1775.
-
(2012)
Biochim Biophys Acta.
, vol.1817
, pp. 1768-1775
-
-
González-Barroso, M.M.1
Anedda, A.2
Gallardo-Vara, E.3
-
52
-
-
84868147963
-
Time-dependent stabilization of hypoxia inducible factor-1a by different intracellular sources of reactive oxygen species
-
Calvani M, Comito G, Giannoni E, Chiarugi P. Time-dependent stabilization of hypoxia inducible factor-1a by different intracellular sources of reactive oxygen species. PLoS One. 2012;7:e38388.
-
(2012)
PLoS One
, vol.7
, pp. e38388
-
-
Calvani, M.1
Comito, G.2
Giannoni, E.3
Chiarugi, P.4
|